NASDAQ: TTRXTurn Therapeutics Inc Stock Ownership - Who owns Turn Therapeutics?
Insider buying vs selling
Have Turn Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Zuraiz Chaudhary | Officer | 2025-11-21 | 1,000 | $3.29 | $3.29kBuy |
| Arthur F. Golden | Director | 2025-11-21 | 20,532 | $2.87 | $58.93kBuy |
| Zuraiz Chaudhary | Officer | 2025-11-20 | 1,450 | $2.61 | $3.78kBuy |
| Zuraiz Chaudhary | Officer | 2025-11-17 | 2,500 | $3.62 | $9.05kBuy |
| Zuraiz Chaudhary | Officer | 2025-10-23 | 5,050 | $4.95 | $25.00kBuy |
| Abraham Chesed | Insider | 2025-10-23 | 14,286 | $4.60 | $65.72kBuy |
| Arthur F. Golden | Director | 2025-10-23 | 20,202 | $4.95 | $100.00kBuy |
TTRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TTRX insiders and whales buy or sell their stock.
TTRX Shareholders
What type of owners hold Turn Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bradley Evan Burnam | 54.39% | 16,016,260 | $52.37M | Insider |
| Abraham Chesed | 4.92% | 1,447,268 | $4.73M | Insider |
| Arthur F. Golden | 0.17% | 50,734 | $165.90k | Insider |
| Kent Edward Kester | 0.03% | 10,000 | $32.70k | Insider |
| Neilesh Shailesh Ghodadra | 0.03% | 10,000 | $32.70k | Insider |
| Zuraiz Chaudhary | 0.03% | 10,000 | $32.70k | Insider |
| Andrew Gengos | 0.03% | 10,000 | $32.70k | Insider |
TTRX vs Biotech Stocks
Turn Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.